Sphinganine

Sphinganine is a lipid of Sphingolipids (SP) class. Sphinganine is associated with abnormalities such as Sphingolipidoses, CLEFT LIP, CONGENITAL HEALED, Aortic aneurysm, familial thoracic 4, Morphologically altered structure and Atherosclerosis. The involved functions are known as Transcription, Genetic, Signal, Muscle Contraction, biological adaptation to stress and Gene Expression. Sphinganine often locates in Tissue membrane, Membrane, Protoplasm, Plasma membrane and Cytoplasmic. The associated genes with Sphinganine are SLC33A1 gene, HM13 gene, P4HTM gene, SPHK1 gene and SPHK2 gene. The related lipids are Sphingolipids, Phosphatidylserines, Sterols, Fatty Acids and inositolphosphorylceramide. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of Sphinganine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphinganine?

Sphinganine is suspected in Pulmonary Edema, Morphologically altered structure, Infection, HIV Infections, Pulmonary Hypertension, Exanthema and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphinganine

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Swine Diseases D013553 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Abortion, Spontaneous D000022 12 associated lipids
Total 5

PubChem Associated disorders and diseases

What pathways are associated with Sphinganine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphinganine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphinganine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphinganine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphinganine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphinganine?

Knock-out

Knock-out are used in the study 'Sphingolipids are required for the stable membrane association of glycosylphosphatidylinositol-anchored proteins in yeast.' (Watanabe R et al., 2002) and Knock-out are used in the study 'Role for de novo sphingoid base biosynthesis in the heat-induced transient cell cycle arrest of Saccharomyces cerevisiae.' (Jenkins GM and Hannun YA, 2001).

Mouse Model

Mouse Model are used in the study 'Palmitate increases sphingosine-1-phosphate in C2C12 myotubes via upregulation of sphingosine kinase message and activity.' (Hu W et al., 2009).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphinganine

Download all related citations
Per page 10 20 50 100 | Total 790
Authors Title Published Journal PubMed Link
pmid:
Tokuda H et al. Extracellular sphingomyelinase induces interleukin-6 synthesis in osteoblasts. 1999 J. Cell. Biochem. pmid:10022508
Tolleson WH et al. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion. 1999 Int. J. Oncol. pmid:10200332
Chen N et al. Translocation of protein kinase Cepsilon and protein kinase Cdelta to membrane is required for ultraviolet B-induced activation of mitogen-activated protein kinases and apoptosis. 1999 J. Biol. Chem. pmid:10336426
Yang L et al. Sphingosine 1-phosphate formation and intracellular Ca2+ mobilization in human platelets: evaluation with sphingosine kinase inhibitors. 1999 J. Biochem. pmid:10393324
Yoon HT et al. Improved fluorescent determination method of cellular sphingoid bases in high-performance liquid chromatography. 1999 Arch. Pharm. Res. pmid:10403133
Turner PC et al. Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks. 1999 Mutat. Res. pmid:10415433
Tedesco MM and Matile S Spectroscopic detection of endovesiculation by large unilamellar phosphatidylcholine vesicles: effects of chlorpromazine, dibucaine, and safingol. 1999 Bioorg. Med. Chem. pmid:10465411
Touyz RM and Schiffrin EL Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. 1999 Hypertension pmid:10523394
Grilley MM and Takemoto JY Assay of the Saccharomyces cerevisiae dihydrosphingosine C-4 hydroxylase. 2000 Meth. Enzymol. pmid:10563305
Lynch DV Enzymes of sphingolipid metabolism in plants. 2000 Meth. Enzymol. pmid:10563318
Riley RT and Plattner RD Fermentation, partial purification, and use of serine palmitoyltransferase inhibitors from Isaria (= Cordyceps) sinclairii. 2000 Meth. Enzymol. pmid:10563339
Bielawska A et al. Radiolabeling of the sphingolipid backbone. 2000 Meth. Enzymol. pmid:10563345
Sonnino S et al. Preparation of radioactive gangliosides, 3H or 14C isotopically labeled at oligosaccharide or ceramide moieties. 2000 Meth. Enzymol. pmid:10563353
Castro AF et al. Mechanism of inhibition of P-glycoprotein-mediated drug transport by protein kinase C blockers. 1999 Biochem. Pharmacol. pmid:10571246
Xu K and Thornalley PJ Antitumour activity of sphingoid base adducts of phenethyl isothiocyanate. 2000 Bioorg. Med. Chem. Lett. pmid:10636242
Nowak DM et al. Sphingosine and sphinganine levels in human mesothelial cells in vitro as a potential index of signal transduction pathways impacted by microbes and osmolality. 1998 Adv Perit Dial pmid:10649716
van der Westhuizen L et al. Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa. 1999 Food Chem. Toxicol. pmid:10654591
Sharma C et al. Inhibition of Ca2+ release channel (ryanodine receptor) activity by sphingolipid bases: mechanism of action. 2000 Chem. Phys. Lipids pmid:10660207
Jarvis WD and Grant S Protein kinase C targeting in antineoplastic treatment strategies. 1999 Invest New Drugs pmid:10665476